Purpose

This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

Perinatal IPV survivors are eligible if they: - 1) feel comfortable completing the study in Spanish or English - 2) are age 18 or older - 3) are no more than 24 weeks 6 days gestation (note: participants enrolled earliest at 18 weeks, baseline at 22 weeks with a 3 week window) - 4) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV - 5) live within a 50 mile radius of Pittsburgh, Pennsylvania - 6) able to provide safe and complete contact information or take a study cell phone

Exclusion Criteria

  • Unable to consent - Do not meet inclusion criteria - Cannot provide safe contact information or take a study cell phone - Incarcerated

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Single (Investigator)
Masking Description
The trial will be blinded to the investigators and participants will be unblinded if a participant is experiencing distress or needs support from the primary investigator

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Active control arm
The active control arm will include two structured check-ins by a trained intimate partner violence advocate from a local victim services agency. The IPV advocate will check in twice: once prenatally (after randomization) and the next postpartum. All participants in the active control arm will have access to the 24/7 helpline.
  • Behavioral: Thrive
    The active control arm will include pairing intimate partner violence survivors with IPV advocates
Experimental
Doula group (intervention)
The intervention arm will include support rom a community-based doula connected with an IPV survivor during the second trimester and followed for 6 months. The doulas will provide full-spectrum services, which include attending clinic visits, support during the delivery, telephone and virtual check-ins, and connection to resources. Doulas have 4 structured visits (4 hours) and the rest of the time will be unstructured. Doulas will also attend the participant's birth. Doulas will provide a trauma-informed perinatal workbook to the participants that our team developed.
  • Behavioral: Doulas
    The intervention will be pairing intimate partner violence survivors with a trained doula

Recruiting Locations

The Midwife Center
Pittsburgh, Pennsylvania 15222
Contact:
Emily McGahey
(412) 321-6880
e.mcgahey@midwifecenter.org

Family Medicine Department
Pittsburgh, Pennsylvania 15260
Contact:
Stacy Bartlett
412-383-2377
bartlettsj2@upmc.edu

More Details

Status
Recruiting
Sponsor
University of Pittsburgh

Study Contact

Maya Ragavan
4126926545
ragavanm@chp.edu

Detailed Description

The study team will complete a 2-arm randomized clinical trial to test the effectiveness of IPV-trained doulas compared with an active control in reducing IPV among perinatal IPV survivors. Participants randomized into doula group will be paired community doula who will provide full-spectrum doula services prenatally (22 weeks gestation), through the birthing period, to early postpartum (6 months total). Participants randomized to the active two structured intakes from a victim services agency. Participants will be recruited from their prenatal visit at 1 of 3 sites with 125 perinatal people randomized to the doula group and 125 randomized to active control (N=250). The primary outcome is change in IPV across a range coercive behaviors from baseline to 12-months post enrollment. Secondary outcomes include change in cannabis and tobacco use, as well as depressive symptoms, anxiety, and unmet basic needs. The study will also be assessing changes in intermediate outcomes, including resource utilization, trust of doulas and IPV advocates, parenting stress, safety-related empowerment, and social support. Measures will be completed at enrollment, and then 3-, 6-, and 12-months post-enrollment. In Aim 2, the study team will be assessing potential mediators and moderators driving intervention effects and in Aim 3, collecting information about implementation outcomes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.